BR112022024382A2 - Formas sólidas de pralsetinibe - Google Patents

Formas sólidas de pralsetinibe

Info

Publication number
BR112022024382A2
BR112022024382A2 BR112022024382A BR112022024382A BR112022024382A2 BR 112022024382 A2 BR112022024382 A2 BR 112022024382A2 BR 112022024382 A BR112022024382 A BR 112022024382A BR 112022024382 A BR112022024382 A BR 112022024382A BR 112022024382 A2 BR112022024382 A2 BR 112022024382A2
Authority
BR
Brazil
Prior art keywords
pralsetinib
forms
solid forms
solid
pyrazol
Prior art date
Application number
BR112022024382A
Other languages
English (en)
Inventor
Waetzig Joshua
D Wilkie Gordon
Maceachern Lauren
Jean Miller Kimberly
Original Assignee
Blueprint Medicines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueprint Medicines Corp filed Critical Blueprint Medicines Corp
Publication of BR112022024382A2 publication Critical patent/BR112022024382A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

FORMAS SÓLIDAS DE PRALSETINIBE. O composto cis)-N-((S)-1-(6-(4-fluoro-1H-pirazol-1-il)piridin-3-il)etil)-1-metoxi-4-(4-metil-6-(5-metil-1H-pirazol-3-ilamino)pirimidin-2-il)ciclo-hexanocarboxamida pode ser preparado como uma base livre em várias formas sólidas cristalinas e em várias formas de sal, cada uma tendo uma ou mais formas sólidas.
BR112022024382A 2020-05-29 2021-05-28 Formas sólidas de pralsetinibe BR112022024382A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063032121P 2020-05-29 2020-05-29
US202063047353P 2020-07-02 2020-07-02
PCT/US2021/034823 WO2021243192A1 (en) 2020-05-29 2021-05-28 Solid forms of pralsetinib

Publications (1)

Publication Number Publication Date
BR112022024382A2 true BR112022024382A2 (pt) 2023-05-02

Family

ID=76601779

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022024382A BR112022024382A2 (pt) 2020-05-29 2021-05-28 Formas sólidas de pralsetinibe

Country Status (12)

Country Link
US (1) US20230295121A1 (pt)
EP (1) EP4157829A1 (pt)
JP (1) JP2023527412A (pt)
KR (1) KR20230017234A (pt)
CN (1) CN116075503A (pt)
AU (1) AU2021281365A1 (pt)
BR (1) BR112022024382A2 (pt)
CA (1) CA3183728A1 (pt)
IL (1) IL298523A (pt)
MX (1) MX2022014858A (pt)
TW (1) TW202210468A (pt)
WO (1) WO2021243192A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3773589T (lt) 2018-04-03 2024-02-12 Blueprint Medicines Corporation Ret inhibitorius, skirtas naudoti vėžiui gydyti, esant ret pakitimui
EP4229047A1 (en) * 2020-10-19 2023-08-23 Teva Pharmaceuticals International GmbH Solid state forms of pralsetinib and process for preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI787018B (zh) 2015-11-02 2022-12-11 美商纜圖藥品公司 轉染過程重排之抑制劑

Also Published As

Publication number Publication date
CA3183728A1 (en) 2021-12-02
MX2022014858A (es) 2023-02-23
JP2023527412A (ja) 2023-06-28
WO2021243192A1 (en) 2021-12-02
KR20230017234A (ko) 2023-02-03
AU2021281365A1 (en) 2022-12-15
TW202210468A (zh) 2022-03-16
EP4157829A1 (en) 2023-04-05
US20230295121A1 (en) 2023-09-21
IL298523A (en) 2023-01-01
CN116075503A (zh) 2023-05-05

Similar Documents

Publication Publication Date Title
BR112022024382A2 (pt) Formas sólidas de pralsetinibe
CY1124815T1 (el) ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ ΚΑΙ ΦΑΡΜΑΚΟΤΕΧΝΙΚΕΣ ΜΟΡΦΕΣ ΤΟΥ (S)-4-(8-AMINO-3-(l-1BOYT-2-YNOΫΛO)ΠYPPOΛIΔIN-2-YΛO) ΙΜΙΔΑΖΟ[1,5-Α]ΠΥΡΑΖΙΝ-1-ΥΛΟ)-Ν-(ΠΥΡΙΔΙΝ-2-ΥΛΟ) ΒΕΝΖΑΜΙΔΙΟΥ
BR112022003375A2 (pt) Compostos de pirazina-amida pesticidamente ativos
JOP20200340A1 (ar) مركبات آزول-أميد النشطة من الناحية المبيدة للآفات
BR112021019987A2 (pt) Compostos de diazina-amida pesticidamente ativos
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
EA200800201A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
CY1112762T1 (el) ΕΤΕΡΟΑΡΥΛΟ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΠΥΡΡΟΛΟ[2,3-b] ΠΥΡΙΔΙΝΕΣ ΚΑΙ ΠΥΡΡΟΛΟ [2,3-b] ΠΥΡΙΜΙΔΙΝΕΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΚΙΝΑΣΗΣ JANUS
HRP20041177B1 (hr) Mikrobicidni pirimidini ili triazini za prevenciju prijenosa hiv seksualnim putem
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
HRP20080377B1 (hr) ANTAGONISTI AKTIVIN-ActRIIa I PRIMJENE ZA STIMULACIJU RASTA KOSTI
AR059027A1 (es) Administracion de inhibidores de dipeptidil peptidasa
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
BR112021018495A2 (pt) Compostos de azolamida ativos em termos pesticidas
BR112021018501A2 (pt) Compostos de azolamida ativos em termos pesticidas
PE20200329A1 (es) Procedimiento para establecer permisos de usuario en unidad de intercambio de informacion en el sistema
ECSP22038978A (es) INHIBICIÓN DE INTEGRINA ALFA4ß7 HUMANA
UY34191A (es) ?N-(6-((2R,3S)-3,4-Dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pirimidin-4-il)-3-metilazetidina-1-sulfonamida y sales farmacéuticamente aceptables de lamisma?.
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
SG151288A1 (en) 3-cyano-quinoline derivatives with antiproliferative activity
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
GEP20217269B (en) Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof
SE0301654D0 (sv) Novel compounds
BR0307286A (pt) Tratamento de artrite reumatóide usando imatinib
ATE531698T1 (de) 4-aminocarbonylamino-substitutierte imidazolverbindungen mit antiviraler wirkung